The downgrade from Overweight to Equal-Weight by a major financial institution like Morgan Stanley suggests a less bullish outlook on DRVN's stock, which could lead to a decrease in investor confidence and a potential drop in the stock price in the short term. The reduction in the price target further emphasizes a more conservative valuation of the company.